Brief: X4 Pharmaceuticals Reports Q3 2024 Financial Results And Provides Corporate Update
13/11/2024 12:52
Nov 13 (Reuters) - X4 Pharmaceuticals Inc XFOR.O :
* X4 PHARMACEUTICALS REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* X4 PHARMACEUTICALS: CO HAD $135.8 MILLION IN CASH, CASH
EQUIVALENTS, RESTRICTED CASH, & SHORT-TERM MARKETABLE SECURITIES
AS OF SEPT 30, 2024
Source text: urn:newsml:reuters.com:*:nGNX5FQyZ8
Further company coverage: XFOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule